Purchase Order 75D30122P15630

The Centers for Disease Control and Prevention has awarded a $300,000 firm fixed price purchase order to Nanocomposix, Inc. for lateral flow assay devices. The contract has no set-aside designation and runs through September 2023. Nanocomposix will deliver the requested lateral flow assay products to CDC under this contract. As a manufacturer of engineered nanoparticles located in San Diego, California, Nanocomposix has extensive experience providing lateral flow assays, gold nanoparticles, and research services involving biomedical technologies to agencies such as HHS, DoD, NIH, FDA, and CDC through various prime contracts and subcontracts. This includes developing the first rapid diagnostic test for Paragonimus infections under prior NIH funding.